European capital meets America

Funding Moves

Funding rounds, IPOs and U.S. capital-market moves by European companies, newest first.

Windward Bio targets near-$1bn valuation in US IPO
Funding

Windward Bio targets near-$1bn valuation in US IPO

Basel-based Windward Bio plans a Nasdaq IPO that would value it at nearly $1 billion, bringing its long-acting respiratory and dermatology drug pipeline to US public investors.

Switzerland→U.S.

11 Nov 2026

Swiss dental company vVardis files for U.S. IPO after revenue triples
Capital Markets

Swiss dental company vVardis files for U.S. IPO after revenue triples

Swiss dental technology company vVardis has filed for a U.S. IPO as it scales its footprint across the American dental market. The Swiss-founded business generated $28.6 million in first-half 2026 revenue and says its products have already reached more than 20,000 U.S. dental practices.

Switzerland→New York, NY

15 Oct 2026

AstraZeneca drops $2B into an American biotech
Expansion

AstraZeneca drops $2B into an American biotech

AstraZeneca is investing $2 billion in Miami-based Summit Therapeutics, giving the British pharmaceutical group rights equivalent to roughly 12% of Summit's outstanding common stock while the two companies launch a new cancer-treatment collaboration.

United Kingdom→Miami, FL

29 Sep 2026

Finland-born ŌURA targets $15.6B valuation in Nasdaq IPO
Capital Markets

Finland-born ŌURA targets $15.6B valuation in Nasdaq IPO

Finland-born ŌURA is offering 50 million shares at $40 to $44 in a U.S. IPO that could reach $2.2 billion. But only 13.5 million shares are being sold by the company itself, with most of the offering coming from existing shareholders.

Finland→San Francisco, CA

28 Sep 2026

Newcleo Lands on Nasdaq With $247M for U.S. Growth
Funding

Newcleo Lands on Nasdaq With $247M for U.S. Growth

Advanced nuclear company newcleo has begun trading on Nasdaq under the ticker NWCL after completing a $247 million transaction. The company plans to use the capital to support U.S. and European growth, including American regulatory and commercial activity.

United Kingdom→New York, NY

23 Sep 2026

FintechOS Raises $28M as U.S. Business Grows 130%
Funding

FintechOS Raises $28M as U.S. Business Grows 130%

FintechOS has raised $28 million in equity and debt after its U.S. business grew 130% in the first half of 2026. The company plans to use the capital to deepen its American expansion while adding financial institutions on both sides of the Atlantic.

Romania→U.S.

22 Sep 2026

Ryft Raises £20M to Fuel U.S. Payments Expansion
Funding

Ryft Raises £20M to Fuel U.S. Payments Expansion

Ryft has raised £20 million in Series B funding after tripling its processing volume over the past year. The Manchester fintech plans to use the capital to expand across Europe and the United States.

United Kingdom→U.S.

21 Sep 2026

Nscale Files for NYSE IPO as U.S. AI Push Accelerates
News

Nscale Files for NYSE IPO as U.S. AI Push Accelerates

British AI infrastructure company Nscale has filed for a U.S. IPO and plans to list on the New York Stock Exchange under the ticker NSCL. The filing comes as Nscale rapidly expands its American AI infrastructure footprint.

United Kingdom→New York, NY

20 Sep 2026

Revolut Eyes New York in Potential Dual IPO Listing
Fintech

Revolut Eyes New York in Potential Dual IPO Listing

Revolut is considering a dual stock-market listing in New York and London, with CEO Nik Storonsky openly favoring the depth of U.S. capital markets. The move would pair its expanding American banking ambitions with a possible Nasdaq debut.

United Kingdom→New York, NY

19 Sep 2026

Europe → America Weekly

One sharp briefing on the companies and founders scaling in the U.S.